跳至主要内容
临床试验/ITMCTR2000003264
ITMCTR2000003264已完成1 期

Standardisation of syndrome differentiation and exploring Chinese herbal medicine use for early breast cancer

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
24 至 79(—)
性别
Female

入选标准

  • 1. Patients whose pathology meets the diagnostic criteria of early breast cancer (stage I-III, excluding distant metastasis);
  • 2. Female patients over 18 years old (including 18 years old);
  • 3. Patients with a score of 0-2 in ECoG (Eastern Cooperative Oncology Group);
  • 4. Patients who voluntarily participated in the study and signed informed consent.

排除标准

  • 1. Patients with severe cardiovascular and cerebrovascular diseases or mental related diseases;
  • 2. Patients who receive neoadjuvant therapy or chemotherapy, radiotherapy and endocrine therapy at the same time;
  • 3. Pregnant or lactating women.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验